(b)(5).During processing of this complaint, attempts were made to obtain complete event, patient and device information.The steerable guide catheter was discarded.Investigation is not yet completed.A follow up report will be submitted with all relevant informatation.
|
This event is filed for bleeding at the access site, which required intervention.It was reported that on (b)(6) 2016, the patient, with degenerative mitral regurgitation, underwent a mitraclip procedure, with implantation of two clips, reducing the mitral regurgitation (mr) from grade 3+ to 1+.Post procedure, the patient experienced a non-serious left femoral hemorrhage and swelling at the mitraclip access site.Compression was performed and the event resolved.No additional information was provided.
|
(b)(4).The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot.The reported patient effect of hemorrhage, as listed in the mitraclip system instructions for use is a known possible complication associated with mitraclip procedures.Based on the information reviewed, the reported patient effects of hemorrhage and swelling appear to be related to case-specific circumstances as they occurred after the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|